Literature DB >> 1792415

Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit.

C Feldman1, J M Kallenbach, H Levy, J R Thorburn, M D Hurwitz, H J Koornhof.   

Abstract

In a study of 41 consecutive patients with bacteraemia-associated community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae an attempt was made to determine whether distinguishing criteria of disease due to these organisms could be identified according to demographic features and the results of initial clinical and laboratory investigations. Such information would aid in the early initiation of appropriate antimicrobial therapy. The most significant difference between the two groups of patients was the lower platelet count in the K. pneumoniae group (p less than 0.005). In addition leucopenia (p less than 0.05), higher serum albumin (p less than 0.05), and the male sex (p less than 0.05) featured with an increased frequency in patients with pulmonary infection due to K. pneumoniae. Initial antimicrobial therapy in critically ill patients with community-acquired lobar pneumonia and thrombocytopenia, particularly when associated with leucopenia and in male patients, should include agents effective against K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792415     DOI: 10.1159/000195943

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

3.  Purification and in vitro activities of rabbit platelet microbicidal proteins.

Authors:  M R Yeaman; Y Q Tang; A J Shen; A S Bayer; M E Selsted
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice.

Authors:  E Wang; N Ouellet; M Simard; I Fillion; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release.

Authors:  Darin A Trier; Kimberly D Gank; Deborah Kupferwasser; Nannette Y Yount; William J French; Alan D Michelson; Leon I Kupferwasser; Yan Q Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

6.  Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008.

Authors:  Yi-Tsung Lin; Yuan-Yu Jeng; Te-Li Chen; Chang-Phone Fung
Journal:  BMC Infect Dis       Date:  2010-10-25       Impact factor: 3.090

7.  Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

Review 8.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

9.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.

Authors:  Lihong Chen; Chun Wang; Hengchuan Liu; Guanjian Liu; Xingwu Ran
Journal:  J Diabetes Res       Date:  2013-02-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.